A program to help turn research discoveries into clinical treatments for heart, lung, blood, and sleep diseases.
Coordinating Center for the NHLBI Catalyze Program
['FUNDING_OTHER'] · RESEARCH TRIANGLE INSTITUTE · NIH-10684451
This program is helping scientists turn their exciting new ideas for treating heart, lung, blood, and sleep problems into real medicines that can help patients like you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | RESEARCH TRIANGLE INSTITUTE (nih funded) |
| Locations | 1 site (RESEARCH TRIANGLE PARK, UNITED STATES) |
| Trial ID | NIH-10684451 on ClinicalTrials.gov |
What this research studies
This program aims to bridge the gap between laboratory research and clinical application, often referred to as the 'Valley of Death.' It provides funding, technical support, and skills development to researchers working on novel therapies for heart, lung, blood, and sleep disorders. By offering guidance from initial discovery through to the stages required for regulatory approval, the program seeks to accelerate the development of important medical treatments. Patients may benefit from new therapies that emerge from this translational research initiative.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals suffering from heart, lung, blood, or sleep-related diseases.
Not a fit: Patients with conditions unrelated to heart, lung, blood, or sleep disorders may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of innovative treatments for various heart, lung, blood, and sleep disorders.
How similar studies have performed: Previous programs aimed at bridging the translational gap have shown success in advancing medical treatments, indicating that this approach has potential.
Where this research is happening
RESEARCH TRIANGLE PARK, UNITED STATES
- RESEARCH TRIANGLE INSTITUTE — RESEARCH TRIANGLE PARK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SEVERYNSE-STEVENS, DIANA M — RESEARCH TRIANGLE INSTITUTE
- Study coordinator: SEVERYNSE-STEVENS, DIANA M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.